Tahsin Özatlı

Akademik Profiller

1. 1
   Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer TestingCancer Genomics and Proteomics
   2023
2. 2
   Comprehensive tumor molecular profile analysis in clinical practiceBMC Medical Genomics
   2021
3. 3
   A Comprehensive Tumor Molecular Profile Analysis in Clinical Practice: A Single Center’s ExperienceResearch Square
   2020
4. 4
   Predictive and prognostic factors in ovarian and uterine carcinosarcomasBalkan Medical Journal
   2016
5. 5
   Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO)Thoracic Cancer
   2015
6. 6
   KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinomaJournal of B.U.ON.
   2015
7. 7
   Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimenMedical Oncology
   2014
8. 8
   Sequential therapy and prognostic factors in metastatic renal cell carcinoma: Single centre experienceJournal of B.U.ON.
   2014
9. 9
   Treatment and prognostic factors in primary peritoneal carcinoma: A multicenter study of the anatolian society of medical oncology (ASMO)Oncology Research and Treatment
   2014
10. 10
    An overall view on nosocomial infections in an intensive care unit,Yoǧun bakım ünitesinde hastane enfeksiyonlarına kapsamlı bir bakışTurkiye Klinikleri Journal of Medical Sciences
    2010

Yayın listesi ORCID kaydından alındı.